Oova
2 known investors
Oova is a clinical-grade hormone testing platform that uses smartphone scanning of test strips paired with AI-powered analysis to measure luteinizing hormone, estrogen, and progesterone levels. The service targets women tracking fertility, perimenopause, or general cycle health, with results validated by medical institutions and recommended by healthcare providers.
AI & Machine LearningDigital HealthFemTech
Investors · 2
In the news
- At-Home Hormone Test Maker Oova Raises $10.3M In Series A Funding | Beauty Independentbeautyindependent.com · 2023
- Oova, a Mount Sinai spinoff startup, raises $10.3 million in funding for fertility testing kit - Tech Startupstechstartups.com · 2023
- Oova Raises $10.3M in Series A Funding for Its Fertility Tracking Solution | Femtech Insiderfemtechinsider.com · 2023
- Oova - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Oova - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Oova raises $1.2M to develop a better at-home kit for detecting a woman’s best time to conceive | TechCrunchtechcrunch.com · 2021